The solutions towards a cure are multi-faceted and complex at best. There is a new technology, used and performed in Switzerland, Germany, at Oxford, Harvard, and at a few other private locations, called “CRISPR genetic modification therapy.” This technology needs further testing and much greater recognition of its potential.
-Monsanto will cure and modify our crops, what we eat, but not let us cure us?
https://www.statnews.com/2016/09/22/monsanto-licenses-crispr/
-Take a look at ‘HDBuzz‘ on CRISPR and Gene Therapy:
Dr. Nicole Déglon, a neuroscientist at the University of Lausanne in Switzerland, says “CRISPR’s results are remarkably encouraging [and as] neurological diseases go, Huntington’s is an ideal candidate for CRISPR therapy, because the disease is determined by a single gene”.
-Read this article about Dr. Nicole Déglon’s first successful Huntington’s gene-editing clinical trial in mice using CRISPR:
Dr. Déglon is the first scientist to apply this technology on Huntington’s using mice. She had amazing results: a 90% blockage on disease production rate, using CRISPR-Cas9.
I have been in contact with Dr. Déglon, Harvard Dr. Jong-Min Lee, and with some of these doctors and scientists, from around the world. We are trying to set up a game plan, to eventually meet face-to-face and initiate my Huntington’s Initiative, backed by friends, family members, teachers, and doctors, all pursuing a cure. We radiate hope, believe in greatness, and envision a greater tomorrow.
*Wave Life Sciences is currently pre-clinical and seeking only early manifest Huntington’s Disease patients with certain genetic markers, however this is a foot in the right direction and could prove promising.
https://www.wavelifesciences.com/pipeline/clinical-trials/#huntingtons-disease
A new breakthrough article using CRISPR was just published regarding the true onset of Huntington’s Disease and how to most effectively treat it :
“The findings are significant in that they led the researchers to believe that existing treatments, therapies that block HTT protein activity, may be doing more harm than good.”
Dr. Déglon is the first scientist to attempt applying CRISPR gene modifying technology on Huntington’s Disease in mice successfully. This inspires many to believe there’s hope in paving the road to the cure of many, if not all, genetic diseases.
Dr. Déglon is part of the team. Not only is Dr. Deglon a part of the team, but she’s stated I’m more than welcome to visit her Switzerland laboratory, where we can further discuss experiments and research. We will be in touch again shortly.
Mice are animals; humans are animals. We have the technology, we just need to employ it more effectively. A permanent solution at last; no more waiting, no more follow-up costly temporary fixes, a real fix.